339 related articles for article (PubMed ID: 24716748)
1. Surfactant treatment for neonatal respiratory disorders other than respiratory distress syndrome.
Alkan S; Ozer EA; Ilhan O; Sutcuoglu S; Tatli M
J Matern Fetal Neonatal Med; 2015 Jan; 28(2):131-3. PubMed ID: 24716748
[TBL] [Abstract][Full Text] [Related]
2. Frequency, causes and outcome of neonates with respiratory distress admitted to Neonatal Intensive Care Unit, National Institute of Child Health, Karachi.
Parkash A; Haider N; Khoso ZA; Shaikh AS
J Pak Med Assoc; 2015 Jul; 65(7):771-5. PubMed ID: 26160089
[TBL] [Abstract][Full Text] [Related]
3. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors of Respiratory Diseases Among Neonates in Neonatal Intensive Care Unit of Qena University Hospital, Egypt.
Baseer KAA; Mohamed M; Abd-Elmawgood EA
Ann Glob Health; 2020 Feb; 86(1):22. PubMed ID: 32140431
[TBL] [Abstract][Full Text] [Related]
5. Incidence and etiology of late preterm admissions to the neonatal intensive care unit and its associated respiratory morbidities when compared to term infants.
Mally PV; Hendricks-Muñoz KD; Bailey S
Am J Perinatol; 2013 May; 30(5):425-31. PubMed ID: 23096053
[TBL] [Abstract][Full Text] [Related]
6. Full-term neonatal intenstive care unit admission in an urban community hospital: the role of respiratory morbidity.
Horowitz K; Feldman D; Stuart B; Borgida A; Ming Victor Fang Y; Herson V
J Matern Fetal Neonatal Med; 2011 Nov; 24(11):1407-10. PubMed ID: 21299397
[TBL] [Abstract][Full Text] [Related]
7. Exogenous surfactant therapy in newborns.
Rodriguez RJ; Martin RJ
Respir Care Clin N Am; 1999 Dec; 5(4):595-616. PubMed ID: 10565883
[TBL] [Abstract][Full Text] [Related]
8. Surfactant replacement therapy in the neonate: beyond respiratory distress syndrome.
Donn SM; Dalton J
Respir Care; 2009 Sep; 54(9):1203-8. PubMed ID: 19712497
[TBL] [Abstract][Full Text] [Related]
9. Surfactant reduced the mortality of neonates with birth weight ⩾1500 g and hypoxemic respiratory failure: a survey from an emerging NICU network.
Wang H; Gao X; Liu C; Yan C; Lin X; Dong Y; Sun B
J Perinatol; 2017 Jun; 37(6):645-651. PubMed ID: 28151493
[TBL] [Abstract][Full Text] [Related]
10. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants.
Wang H; Gao X; Liu C; Yan C; Lin X; Yang C; Lin Z; Zhu W; Yang Z; Yu F; Qiu Y; Liu X; Zhou X; Chen C; Sun B;
Pediatrics; 2012 Mar; 129(3):e731-40. PubMed ID: 22331337
[TBL] [Abstract][Full Text] [Related]
11. Surfactant therapy in full-term neonates with severe respiratory failure.
Khammash H; Perlman M; Wojtulewicz J; Dunn M
Pediatrics; 1993 Jul; 92(1):135-9. PubMed ID: 8516059
[TBL] [Abstract][Full Text] [Related]
12. [Respiratory disorders in preterm and term neonates: an update on diagnostics and therapy].
Gortner L; Tutdibi E
Z Geburtshilfe Neonatol; 2011 Aug; 215(4):145-51. PubMed ID: 21863529
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary surfactant for neonatal respiratory disorders.
Merrill JD; Ballard RA
Curr Opin Pediatr; 2003 Apr; 15(2):149-54. PubMed ID: 12640270
[TBL] [Abstract][Full Text] [Related]
14. Surfactant treatment in premature infants with Respiratory Distress Syndrome in Curaçao.
Verhagen AA; Keli SO; van der Meulen GN; Wiersma H; Arias M; Angelista IR; Muskiet FD
West Indian Med J; 2001 Jun; 50(2):117-22. PubMed ID: 11677907
[TBL] [Abstract][Full Text] [Related]
15. The role of surfactant treatment in preterm infants and term newborns with acute respiratory distress syndrome.
Wirbelauer J; Speer CP
J Perinatol; 2009 May; 29 Suppl 2():S18-22. PubMed ID: 19399004
[TBL] [Abstract][Full Text] [Related]
16. Surfactant therapy in neonates with respiratory deterioration due to pulmonary hemorrhage.
Pandit PB; Dunn MS; Colucci EA
Pediatrics; 1995 Jan; 95(1):32-6. PubMed ID: 7770305
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors, frequency and severity of bronchopulmonary dysplasia (BPD) diagnosed according to the new disease definition in preterm neonates].
Woynarowska M; Rutkowska M; Szamotulska K
Med Wieku Rozwoj; 2008; 12(4 Pt 1):933-41. PubMed ID: 19471069
[TBL] [Abstract][Full Text] [Related]
18. Surfactant Replacement Therapy Beyond Respiratory Distress Syndrome in Neonates.
Jasani B; Kabra N; Nanavati R
Indian Pediatr; 2016 Mar; 53(3):229-34. PubMed ID: 27029686
[TBL] [Abstract][Full Text] [Related]
19. Comparison outcomes of surfactant therapy in respiratory distress syndrome in two periods.
Chotigeat U; Promwong N; Kanjanapattanakul W; Khorana M; Sangtawesin V; Horpaopan S
J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S109-14. PubMed ID: 19253505
[TBL] [Abstract][Full Text] [Related]
20. [The clinical comparative study of preterm respiratory distress syndrome and transient tachypnea of newborn].
Liu S; Tong X
Zhonghua Er Ke Za Zhi; 2015 Feb; 53(2):104-8. PubMed ID: 25876684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
